1. Development or worsening of sarcoidosis associated with IL‐17 blockade for psoriasis. (19th May 2020) Authors: Hornick, N.; Wang, A.; Lim, Y.; Gehlhausen, J.; Siegel, J.; Wang, J.; Foss, F.; Lim, I.; Zubek, A.; Milstone, L.; Galan, A.; King, B.; Damsky, W. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 10(2020) Page Start: e583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dupilumab‐induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin‐17A expression: a case report. (1st August 2021) Authors: Mirza, F.N.; Wang, A.; Ramachandran, S.M.; Damsky, W.; Cohen, J.M. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dupilumab‐induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin‐17A expression: a case report. (4th May 2021) Authors: Mirza, F.N.; Wang, A.; Ramachandran, S.M.; Damsky, W.; Cohen, J.M. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Interleukin‐17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis. (6th May 2020) Authors: Wang, A.; Hornick, N.; Lim, Y.; Gehlhausen, J.; Siegel, J.; Wang, J.; Foss, F.; Lim, I.; Zubek, A.; Milstone, L.; Galan, A.; King, B.; Damsky, W. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 9(2020) Page Start: e497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Response to Tembhre et al.: 'Enhanced expression of angiotensin‐converting enzyme 2 in psoriatic skin and its upregulation in keratinocytes by interferon‐γ: implication of inflammatory milieu in skin tropism of SARS‐CoV‐2'. (1st May 2021) Authors: Gehlhausen, J.R.; Ko, C.J.; Damsky, W. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Response to Tembhre et al.: 'Enhanced expression of angiotensin‐converting enzyme 2 in psoriatic skin and its upregulation in keratinocytes by interferon‐γ: implication of inflammatory milieu in skin tropism of SARS‐CoV‐2'. (1st February 2021) Authors: Gehlhausen, J.R.; Ko, C.J.; Damsky, W. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. STATing the obvious: it's time for new treatments in atopic dermatitis. (1st November 2016) Authors: Damsky, W.; King, B.A. Journal: British journal of dermatology Issue: Volume 175:Number 5(2016) Page Start: 861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. STATing the obvious: it's time for new treatments in atopic dermatitis. (28th October 2016) Authors: Damsky, W.; King, B.A. Journal: British journal of dermatology Issue: Volume 175:Number 5(2016) Page Start: 861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗